Cita APA

tafuto, s., Krogh, M., Klümpen, H., Capdevila Castillon, J., Teule, A., & Garcia-Carbonero, R. (2025). Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): A randomized clinical trial.

Citación estilo Chicago

tafuto, salvatore, Merete Krogh, Heinz-Josef Klümpen, Jaume Capdevila Castillon, Alex Teule, y Rocio Garcia-Carbonero. Streptozotocin Plus 5-fluorouracil Followed By Everolimus or the Reverse Sequence in Patients With Advanced Pancreatic Neuroendocrine Tumors (SEQTOR-GETNE Phase III Study): A Randomized Clinical Trial. 2025.

Cita MLA

tafuto, salvatore, et al. Streptozotocin Plus 5-fluorouracil Followed By Everolimus or the Reverse Sequence in Patients With Advanced Pancreatic Neuroendocrine Tumors (SEQTOR-GETNE Phase III Study): A Randomized Clinical Trial. 2025.